Back to Search
Start Over
MP41-15 PROTON PUMP INHIBITOR USE IS A NEGATIVE PROGNOSTIC FACTOR FOR METASTATIC UROTHELIAL CARCINOMA PROGRESSION IN PEMBROLIZUMAB-TREATED PATIENTS
- Source :
- Journal of Urology. 206
- Publication Year :
- 2021
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2021.
-
Abstract
- INTRODUCTION AND OBJECTIVE:Recently, the role of the gut microbiome in inflammatory disease and carcinogenesis has become apparent. Specifically, higher gut microbiome diversity is associated with ...
- Subjects :
- Prognostic factor
Metastatic Urothelial Carcinoma
business.industry
medicine.drug_class
Urology
digestive, oral, and skin physiology
Proton-pump inhibitor
Pembrolizumab
Disease
medicine.disease_cause
digestive system
Gut microbiome
Cancer research
Medicine
business
Carcinogenesis
human activities
Subjects
Details
- ISSN :
- 15273792 and 00225347
- Volume :
- 206
- Database :
- OpenAIRE
- Journal :
- Journal of Urology
- Accession number :
- edsair.doi...........1e1e28f593886420f96dd9e641918c91
- Full Text :
- https://doi.org/10.1097/ju.0000000000002062.15